Parallax Volatility Advisers, L.P. Supernus Pharmaceuticals, Inc. Transaction History

Parallax Volatility Advisers, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$19.93 - $29.13 $171,079 - $250,051	-8,584 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$25.47 - $33.37 $156,869 - $205,525	-6,159 Reduced 41.78%	8,584 $235,000
Q2 2019 Aug 14, 2019	BUY	$29.96 - $38.87 $420,848 - $546,006	14,047 Added 2018.25%	14,743 $488,000
Q1 2019 May 15, 2019	BUY	$32.77 - $41.99 $22,807 - $29,225	696 New	696 $24,000
Q4 2018 Feb 14, 2019	SELL	$30.84 - $49.51 $3,392 - $5,446	-110 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$42.7 - $56.55 $4,697 - $6,220	110 New	110 $6,000
Q1 2018 May 15, 2018	SELL	$37.15 - $46.9 $303,552 - $383,219	-8,171 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$36.4 - $42.6 $297,424 - $348,084	8,171	8,171 $326,000

282

61.1M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.9B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.